Literature DB >> 4416295

The human leukocyte test system. II. Different sensitivities of sub-populations to a chemical mutagen.

B Beek, G Obe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4416295

Source DB:  PubMed          Journal:  Mutat Res        ISSN： 0027-5107            Impact factor:   2.433


× No keyword cloud information.
  7 in total

1.  The human leukocyte test system. V. DNA synthesis and mitoses in PHA-stimulated 3-day cultures.

Authors:  G Obe; B Beek; G Dudin
Journal:  Humangenetik       Date:  1975-08-25

2.  The human leukocyte test system. X. higher sensitivity to X-irradiation in the G0 stage of the cell cycle of early as compared to late replicating cells.

Authors:  B Beek; G Obe
Journal:  Hum Genet       Date:  1976-12-29       Impact factor: 4.132

3.  Age-related alterations in cell division and cell cycle kinetics in control and trimethyltin-treated lymphocytes of human individuals.

Authors:  B B Ganguly
Journal:  Biometals       Date:  1995-07       Impact factor: 2.949

4.  The human leukocyte test system. IX. DNA synthesis and mitoses in PHA-stimulated 2-day cultures set up with Eagle's mimimal essential medium (MEM).

Authors:  G Obe; K Brandt; B Beek
Journal:  Hum Genet       Date:  1976-08-30       Impact factor: 4.132

5.  Relation between sister chromatid exchange, cell proliferation and proportion of B and T cells in human lymphocyte cultures.

Authors:  A Lindblad; B Lambert
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

6.  Differential chromosomal radiosensitivity within the first G1-phase of the cell cycle of early-dividing human leukocytes in vitro after stimulation with PHA.

Authors:  B Beek; G Obe
Journal:  Hum Genet       Date:  1977-02-11       Impact factor: 4.132

7.  Sister chromatid exchanges in human leukocyte chromosomes: spontaneous and induced frequencies in early- and late-proliferating cells in vitro.

Authors:  B Beek; G Obe
Journal:  Hum Genet       Date:  1979-05-23       Impact factor: 4.132
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.